Rob Medical key facts
as of Oct 2026- Developer of medical robot-based technology designed to solve the insufficient high-quality medical resources.
- Rob Medical is valued at approximately $22.5M as of Oct 2026 (last reported valuation).
- It has raised $143.7M; the latest was Later Stage VC in Jul 2025.
- Notable investors include Tailong VC, Hangzhou Capital, Taikun Fund, MGI Tech.
- Status: Privately Held (backing).
Rob Medical's last reported valuation, Sep 2017. Nothing priced has surfaced since.
- ·Watch Rob Medical: the Monday email on marks, rounds and moves
Rob Medical funding rounds
No funding rounds for Rob Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Rob Medical
4Rob Medical valuation
Rob Medical's last reported valuation was $22.5 million in Sep 2017. No priced round, secondary trade or fund mark has surfaced since.
Rob Medical investors
4 investors are on record for Rob Medical, including Tailong VC, Hangzhou Capital, Taikun Fund and MGI Tech.
About Rob Medical
Developer of medical robot-based technology designed to solve the insufficient high-quality medical resources. The company focuses on medical robots, including surgical robots, rehabilitation robots, assistant robots, and service robots, and uses these technologies in clinical fields of natural orifice surgery and ultrasonic diagnosis, enabling patients to enjoy high-quality medical care.
- Sector
- Information Technology
- HQ
- Shenzhen, China
- Founded
- 2015
- Employees
- 10
- Website
- docrobo.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.